Preventing amyloid formation
Nature Structural & Molecular Biology
May 31, 2008
Epigallocatechin gallate, an antioxidant popularly known as EGCG, can prevent the formation of amyloid fibrils, toxic protein aggregates associated with Alzheimer’s and Parkinson’s diseases. The findings, published online this week in Nature Structural & Molecular Biology, may pave the way for the development of more potent compounds designed to prevent amyloid formation associated with several neurodegenerative diseases.
The accumulation of amyloid fibrils in disorders such as Alzheimer’s and Parkinson’s are believed to be caused by the misfolding and aggregation of certain unfolded proteins, which can be toxic to cells and lead to neurodegeneration. Erich Wanker and colleagues show that EGCG, a compound found abundantly in green tea, can bind to these natively unfolded proteins and prevent their conversion to toxic amyloid species. Instead, EGCG directs them to ‘off-pathway’ aggregates that are non-harmful to cells.
Because the authors found that EGCG also binds to unfolded proteins not associated with these diseases, future work could be directed to design compounds that specifically recognize the proteins linked to amyloid formation.
doi: 10.1038/nsmb.1437
Research highlights
-
Nov 26
Evolution: Ancient bird sticks its big beak into the evolutionary recordNature
-
Nov 25
Zoology: Mineral armour discovered in insectsNature Communications
-
Nov 24
Neuroscience: Social isolation evokes craving responses in the human brainNature Neuroscience
-
Nov 20
Archaeology: Transition from tribal to feudal living in 14th century impacted local ecosystemsScientific Reports
-
Nov 18
Ecology: Migration associated with faster pace of lifeNature Communications
-
Nov 17
Gene therapy: Concerns for the long-term safety of AAV gene therapyNature Biotechnology
